Transarterial Chemoembolization Market: How Is TACE Combining with Immunotherapy to Transform HCC Treatment?
TACE and immunotherapy combination strategies — the growing clinical programs combining TACE locoregional tumor destruction with checkpoint inhibitor systemic immunotherapy to leverage the immunogenic cell death generated by embolotherapy for enhanced anti-tumor immunity — represent the most commercially significant development in the TACE market, with the Transarterial...
0 Comments 0 Shares 32 Views 0 Reviews